BRPI0815200A2 - Composição farmacêutica com ação antidiabética, hipolipidêmica, hipoglicêmica e hipocolesterolêmica, e, métodos para a produção da composição farmacêutica, para o tratamento e profilaxia da diabete melito, da hipolipidemia, da hipoglicemia, e de distúrbios hipocolesterolêmicos. - Google Patents

Composição farmacêutica com ação antidiabética, hipolipidêmica, hipoglicêmica e hipocolesterolêmica, e, métodos para a produção da composição farmacêutica, para o tratamento e profilaxia da diabete melito, da hipolipidemia, da hipoglicemia, e de distúrbios hipocolesterolêmicos.

Info

Publication number
BRPI0815200A2
BRPI0815200A2 BRPI0815200A BRPI0815200A2 BR PI0815200 A2 BRPI0815200 A2 BR PI0815200A2 BR PI0815200 A BRPI0815200 A BR PI0815200A BR PI0815200 A2 BRPI0815200 A2 BR PI0815200A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
hypocholesterolemic
hypolipidemia
hypolipidemic
antidiabetic
Prior art date
Application number
Other languages
English (en)
Inventor
Alexander Victorovich Demin
Vitaly Afanasievich Martianov
Alexander Mihaylovich Shuster
Original Assignee
Zakrytoe Aktsionernoe Obschestvo Masterclone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zakrytoe Aktsionernoe Obschestvo Masterclone filed Critical Zakrytoe Aktsionernoe Obschestvo Masterclone
Publication of BRPI0815200A2 publication Critical patent/BRPI0815200A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0815200 2007-09-14 2008-05-22 Composição farmacêutica com ação antidiabética, hipolipidêmica, hipoglicêmica e hipocolesterolêmica, e, métodos para a produção da composição farmacêutica, para o tratamento e profilaxia da diabete melito, da hipolipidemia, da hipoglicemia, e de distúrbios hipocolesterolêmicos. BRPI0815200A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007134267/15A RU2361581C2 (ru) 2007-09-14 2007-09-14 Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
PCT/RU2008/000320 WO2009035368A1 (fr) 2007-09-14 2008-05-22 Composition pharmaceutique possédant un effet antidiabétique

Publications (1)

Publication Number Publication Date
BRPI0815200A2 true BRPI0815200A2 (pt) 2015-03-31

Family

ID=40452228

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815200 BRPI0815200A2 (pt) 2007-09-14 2008-05-22 Composição farmacêutica com ação antidiabética, hipolipidêmica, hipoglicêmica e hipocolesterolêmica, e, métodos para a produção da composição farmacêutica, para o tratamento e profilaxia da diabete melito, da hipolipidemia, da hipoglicemia, e de distúrbios hipocolesterolêmicos.

Country Status (11)

Country Link
US (1) US8247407B2 (pt)
EP (1) EP2204173B1 (pt)
JP (1) JP2010539160A (pt)
KR (1) KR20100086981A (pt)
CN (1) CN101801373B (pt)
AU (1) AU2008297608A1 (pt)
BR (1) BRPI0815200A2 (pt)
CA (1) CA2699403A1 (pt)
MX (1) MX2010002754A (pt)
RU (1) RU2361581C2 (pt)
WO (1) WO2009035368A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3510491A (en) * 1967-02-02 1970-05-05 Sterling Drug Inc 4-(cyclicaminomethyl)-5-hydroxyindole-3-carboxylic acids and esters thereof
US4226829A (en) * 1978-10-04 1980-10-07 Andrew Mike Renewable vaporizer for air treatment and the like
US4889286A (en) * 1988-09-19 1989-12-26 Donald Spector Controllable air freshener unit
FR2674522B1 (fr) 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
DE19753956A1 (de) * 1997-12-05 1999-06-17 Draeger Sicherheitstech Gmbh Duftpatrone
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
WO2004020408A1 (en) 2002-08-29 2004-03-11 Merck & Co., Inc. Indoles having anti-diabetic activity
AR041481A1 (es) 2002-10-07 2005-05-18 Hoffmann La Roche Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
WO2004037169A2 (en) 2002-10-18 2004-05-06 Merck & Co., Inc. Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2005102320A1 (en) * 2004-04-21 2005-11-03 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicinal agent for treating viral infections
US20060233538A1 (en) * 2005-04-14 2006-10-19 Tollens Fernando R Energized systems and devices for delivering volatile materials
US20090326037A1 (en) * 2005-12-28 2009-12-31 Irina Anatolievna Leneva Medicinal Agent For Treating Viral Infections
US20070176015A1 (en) * 2006-01-30 2007-08-02 The Procter & Gamble Company System for delivering volatile materials
WO2007136302A2 (fr) * 2006-05-23 2007-11-29 Alla Chem, Llc Substances actives, composition pharmaceutique et procédé de fabrication et d'utilisations correspondants
EA016633B1 (ru) * 2006-05-23 2012-06-29 Общество С Ограниченной Ответственностью "Инновационная Фармацевтика" Замещенные индолы, способ их получения и применения
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
RU2344817C1 (ru) * 2007-06-19 2009-01-27 Андрей Александрович Иващенко Замещенные эфиры 5-гидрокси-1н-индол-3-карбоновой кислоты, фармацевтическая композиция, способ их получения и применения
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний

Also Published As

Publication number Publication date
EP2204173A4 (en) 2010-12-29
US20100168092A1 (en) 2010-07-01
RU2361581C2 (ru) 2009-07-20
CN101801373B (zh) 2013-03-27
EP2204173A1 (en) 2010-07-07
RU2007134267A (ru) 2009-03-20
EP2204173B1 (en) 2013-07-03
JP2010539160A (ja) 2010-12-16
US8247407B2 (en) 2012-08-21
AU2008297608A1 (en) 2009-03-19
WO2009035368A1 (fr) 2009-03-19
KR20100086981A (ko) 2010-08-02
CN101801373A (zh) 2010-08-11
CA2699403A1 (en) 2009-03-19
MX2010002754A (es) 2010-03-30

Similar Documents

Publication Publication Date Title
CL2007002187A1 (es) Compuestos derivados espirocetal sustituidos; composicion farmaceutica que comprende a dicho compuesto; y su uso para el tratamiento de la diabetes, hiperglicemia, complicaciones diabeticas y obesidad.
AP2011005795A0 (en) SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia.
EP3124045A3 (en) Treatment of il-1 beta related diseases
CL2007003262A1 (es) Compuestos derivados de 1,4-benzotiepina-1,1-dioxido; composicion farmaceutica; y su uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, entre otras enfermedades.
CL2007002186A1 (es) Compuestos derivados espirocetal sustituidos de anillo fusionado; composicion farmaceutica que comprende a dicho compuesto; y uso de la composicion para el tratamiento de la diabetes, hiperglicemia, complicaciones diabeticas y obesidad.
CL2008002424A1 (es) Composicion farmaceutica que comprende un compuesto derivado de pirazol-o-glucosido; y uso de la composicion farmaceutica para el tratamiento de la diabetes mellitus, tolerancia anormal a la glucosa e hiperglucemia, trastornos metabolicos, entre otras.
WO2010049678A3 (en) Treatment of energy utilization diseases
EP2829271A3 (en) Pharmaceutical compositions with (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol and a further antidiabetic agent
CL2007002348A1 (es) Compuestos heterociclicos, moduladores de la actividad de la estearoil-coa-desaturasa; composicion farmaceutica, util para el tratamiento de enfermedades tales como diabetes, dislipidemias, obesidad, anorexia y acne.
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
BRPI0812792A2 (pt) Composição farmacêutica para tratar a diabete e o seu processo de preparação.
BRPI0610127A2 (pt) composição, produto de membrana celulósica, processo para preparar o mesmo, composição para revestimento, tinta, e, processo para produzir a composição
CL2007002841A1 (es) Compuestos derivados de indol, antagonistas del receptor de glucagion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar diabetes mellitus tipo 2, hiperglucemia, diabetes o resistencia a la insulina.
CL2007002904A1 (es) Compuestos derivados de pirazolopirimidina; composicion farmaceutica; y uso para tratar una enfermedad seleccionada de diabetes, obesidad, asma y artritis entre otras.
JP2008521873A5 (pt)
BRPI0716134A2 (pt) tratamento de combinaÇço para diabetes mellitus
CL2013001104A1 (es) Composicion farmaceutica que comprende un inhibidor de sglt2 y una insulina; y uso para tratar una enfermedad o afeccion tal como diabetes mellitus, diabetes mellitus tipo 1 y 2, entre otras.
BRPI0919946A2 (pt) tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
WO2010048207A3 (en) Aryl gpr120 receptor agonists and uses thereof
MY159865A (en) Aqueous insulin preparations containing methionine
IL195755A (en) A therapeutic component for the treatment of obesity, diabetes and impaired glucose tolerance
CL2008001126A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
PA8784101A1 (es) Oxazolidinonas sustituidas y su uso
EP1841781A4 (en) USE OF IL-22 FOR THE TREATMENT OF METABOLISM DISORDER
BRPI0610488A2 (pt) composição polimérica, e, processo para produzir a mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.